MetaVia Inc. (NASDAQ: MTVA) presented Phase 1 clinical trial results for its obesity drug DA-1726 at the European Association for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE